Navigation Links
Forge Therapeutics Scientific Co-Founder Bestowed Prestigious National Chemistry Award
Date:8/19/2015

SAN DIEGO, Aug. 19, 2015 /PRNewswire/ -- Forge Therapeutics, Inc., a biotechnology start-up developing novel small molecule inhibitors that target metalloproteins announced today Dr. Seth Cohen, Ph.D., co-founder of Forge Therapeutics and Professor in the Department of Chemistry and Biochemistry at the University of California, San Diego is the recipient of the Arthur C. Cope Scholar Award administered by the American Chemical Society. 

The Arthur C. Cope Scholar Award is a prize awarded for excellence and achievement in the field of organic chemistry.  Dr. Cohen was named one of the ten Arthur C. Cope Scholars at the American Chemical Society national meeting being held in Boston from August 16-20, 2015 for his pioneering work on metalloprotein chemistry. 

"It is with great pride at Forge Therapeutics that we congratulate Dr. Cohen on being named an Arthur C. Cope Scholar," said Zachary A. Zimmerman, Ph.D., CEO of Forge Therapeutics.  "This award is a high honor in the field of chemistry and further validates the Forge Therapeutics drug discovery platform."

To learn more about the Arthur C. Cope Scholar Award please visit: http://www.acs.org/content/acs/en/funding-and-awards/awards/national/recipients/2016-national-award-recipients.html

About Forge Therapeutics, Inc.

Forge Therapeutics, Inc. ("Forge") is a biotechnology start-up that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins.  Metalloproteins are proteins that require metal ions for their biological function and make up over 1/3 of the proteins in the human body.  Forge uses a proprietary approach comprised of molecular modeling for rational drug design along with fundamental knowledge and expertise in bioinorganic chemistry to target metalloproteins.  Forge is uniquely positioned to discover compounds that inhibit metalloproteins through an innovative process developed at the University of California at San Diego.  Forge possesses rights to key intellectual property for metalloprotein inhibitors. The name Forge Therapeutics comes from two definitions for forge: to manipulate (inhibit) a metal object (metalloprotein) and to move forward steadily with a purpose (the Forge team).  Forge Therapeutics, Inc., maintains its headquarters in San Diego, California.  To learn more please visit www.ForgeTherapeutics.com

Contact:
Info@ForgeTherapeutics.com

Logo - http://photos.prnewswire.com/prnh/20150807/256906LOGO


'/>"/>
SOURCE Forge Therapeutics, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Forge Therapeutics Co-Founder to Present at the 250th American Chemical Society National Meeting
2. Forge Therapeutics Enters Into a Pilot Study with Janssen Research & Development, LLC, to Discover Novel Metalloprotein Inhibitors
3. Genedata and IntelliCyt Forge Alliance to Transform Cell-based Screening in Drug Discovery
4. Bynder and HubCast Forge Global Partnership for Transformative “Concept to Delivery” Solution
5. Never forget a face
6. Tor/Forge Launches THE CURE, a Riveting Thriller in the Tradition of Michael Crichton, by the New York Times Bestselling Author of WIRED.
7. Don't Forget the Payer in Your Digital Strategy: What Payers Need and Want from Pharma
8. Chrysalis BioTherapeutics TP508 Reverses Radiation-Induced GI Damage
9. PTC Therapeutics Announces Closing of $150 Million of Convertible Senior Notes
10. Echo Therapeutics, Inc. Provides Corporate Update and Announces Second Quarter 2015 Financial Results
11. BrainStorm Cell Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of ... award for Excellence in Volunteer Experience from US2020. , US2020’s mission is to ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
(Date:10/9/2017)... Texas (PRWEB) , ... October ... ... study published on October 5, 2017, in the medical journal, Epilepsia, Brain ... with the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) ...
(Date:10/6/2017)... ... October 06, 2017 , ... On Tuesday, October 24th, ABC² ... the first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be ... and open to the public, but registration is required. , WHAT: ABC² ...
Breaking Biology Technology:
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
Breaking Biology News(10 mins):